Ironwood Financial’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,440
Closed -$43K 356
2019
Q4
$43K Hold
1,440
0.02% 125
2019
Q3
$33K Hold
1,440
0.02% 151
2019
Q2
$36K Hold
1,440
0.02% 144
2019
Q1
$35K Hold
1,440
0.02% 148
2018
Q4
$33K Hold
1,440
0.02% 139
2018
Q3
$46K Hold
1,440
0.02% 115
2018
Q2
$52K Buy
1,440
+150
+12% +$5.31K 0.03% 85
2018
Q1
$43K Hold
1,290
0.05% 79
2017
Q4
$40K Hold
1,290
0.02% 95
2017
Q3
$31K Hold
1,290
0.02% 115
2017
Q2
$22K Buy
+1,290
New +$23.2K 0.01% 128

Other funds holding EDIT

Ironwood Financial's EDIT Position: Q1 2020 in Review

Ironwood Financial sold out of Editas Medicine (EDIT) in Q1 2020, closing a stake of 1,440 shares — an estimated $43K sold.

Ironwood Financial first reported a position in EDIT in Q2 2017 and held it in 11 quarters. The position peaked at $52K in Q2 2018. 199 funds tracked by Wall St. Rank hold EDIT as of Q1 2020.

  • Ironwood Financial reported no remaining Editas Medicine position as of Q1 2020 after selling out during the quarter.
  • Ironwood Financial sold 1,440 Editas Medicine shares in Q1 2020, an estimated $43K.
  • Ironwood Financial first reported a position in Editas Medicine in Q2 2017 and held it in 11 quarters.
  • Ironwood Financial's Editas Medicine position peaked at $52K in Q2 2018.
  • 199 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2020.

Based on Ironwood Financial's 13F filing for Q1 2020, filed 27 Apr 2020.